Skip to main content
Top
Published in: Dermatology and Therapy 4/2021

Open Access 01-08-2021 | Azathioprine | Case Report

Behçet’s Disease in a Polish Patient: A Case Report

Authors: Julia Nowowiejska, Anna Baran, Julita A. Krahel, Iwona Flisiak

Published in: Dermatology and Therapy | Issue 4/2021

Login to get access

Abstract

Behçet’s disease (BD) is a systemic autoinflammatory vasculitis. It occurs predominantly in Turkey but very rarely in Europe. The clinical manifestations of BD involve the skin and mucosal membranes; cardiovascular, gastrointestinal and nervous systems; and the eyes and joints. A 26-year-old man was repeatedly hospitalized at the Department of Dermatology of the Medical University of Bialystok. He had a family history of family members' deaths from unknown cause and a long personal history of recurring headaches and nonspecific pain in the chest as well as a 2-year history of recurring painful erosions on the oral mucosa. Recently, before admission to hospital, another erosion had appeared on the scrotum, which rapidly evolved into a painful ulceration. The patient also presented a large erosion in the area of the right hip and acne lesions. He consulted doctors of different specialties and underwent laboratory and imaging tests. Considering the symptoms, BD was diagnosed. Azathioprine was introduced, along with topical treatment. Great improvement of the skin lesions was achieved. He was later admitted to the department a few times for follow-up visits and remains in good general condition. BD is an extremely rare disease in Europe, especially in Poland. The fact that BD is a rare disease outside Asia leads to lower awareness and the possibility of not considering it in the differential diagnosis. The great diversity of symptoms also causes difficulties in tracking this disease. The various manifestations of BD require a broad spectrum of additional tests and an interdisciplinary approach to the patient.
Literature
1.
go back to reference Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, et al. Management of skin, mucosa and joint involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome. Semin Arthritis Rheum. 2019;48:752–62.CrossRef Leccese P, Ozguler Y, Christensen R, Esatoglu SN, Bang D, Bodaghi B, Celik AF, et al. Management of skin, mucosa and joint involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations for the management of Behçet’s syndrome. Semin Arthritis Rheum. 2019;48:752–62.CrossRef
2.
go back to reference Bulur I, Onder M. Behçet disease: new aspects. Clin Dermatol. 2017;35:421–34.CrossRef Bulur I, Onder M. Behçet disease: new aspects. Clin Dermatol. 2017;35:421–34.CrossRef
3.
go back to reference Hu YC, Chiang BL, Yang YH. Clinical manifestations and management of pediatric Behçet’s disease. Clin Rev Allergy Immunol. 2020;7:1–10. Hu YC, Chiang BL, Yang YH. Clinical manifestations and management of pediatric Behçet’s disease. Clin Rev Allergy Immunol. 2020;7:1–10.
4.
go back to reference Scherrer M, Rocha V, Garcia L. Behçet’s disease: review with emphasis on dermatological aspects. An Bras Dermatol. 2017;92:452–64.CrossRef Scherrer M, Rocha V, Garcia L. Behçet’s disease: review with emphasis on dermatological aspects. An Bras Dermatol. 2017;92:452–64.CrossRef
5.
go back to reference Mahr A, Maldini C. Epidemiology of Behçet’s disease. La Revue de Medecine Interne. 2014;35:81–9.CrossRef Mahr A, Maldini C. Epidemiology of Behçet’s disease. La Revue de Medecine Interne. 2014;35:81–9.CrossRef
6.
go back to reference Balta S, Balta I, Ozturk C, Celik T, Iyisoy A. Behçet’s disease and risk of vascular events. Curr Opin Cardiol. 2016;31:451–7.CrossRef Balta S, Balta I, Ozturk C, Celik T, Iyisoy A. Behçet’s disease and risk of vascular events. Curr Opin Cardiol. 2016;31:451–7.CrossRef
7.
go back to reference Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P. Behçet’s disease physiopathology: a contemporary review. Auto Immun Highlights. 2016;7:4.CrossRef Zeidan MJ, Saadoun D, Garrido M, Klatzmann D, Six A, Cacoub P. Behçet’s disease physiopathology: a contemporary review. Auto Immun Highlights. 2016;7:4.CrossRef
8.
9.
go back to reference Leccese P, Yazici Y, Olivieri I. Behcet’s syndrome in nonendemic regions. Curr Opin Rheumatol. 2017;29:12–6.CrossRef Leccese P, Yazici Y, Olivieri I. Behcet’s syndrome in nonendemic regions. Curr Opin Rheumatol. 2017;29:12–6.CrossRef
10.
go back to reference Niedzielska A, Chelminska K, Jaremin B. Behcet’s disease—diagnostic difficulties. Pol Arch Med Wewn. 2007;117:427–9.PubMed Niedzielska A, Chelminska K, Jaremin B. Behcet’s disease—diagnostic difficulties. Pol Arch Med Wewn. 2007;117:427–9.PubMed
11.
go back to reference Romańska-Gocka K, Gocki J, Placek W, et al. Behcet’s disease—case report and literature review. Adv Dermatol Allergol. 2009;26:224–8. Romańska-Gocka K, Gocki J, Placek W, et al. Behcet’s disease—case report and literature review. Adv Dermatol Allergol. 2009;26:224–8.
12.
go back to reference Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet’s disease. Yonsei Med J. 2007;48:573–85.CrossRef Alpsoy E, Zouboulis CC, Ehrlich GE. Mucocutaneous lesions of Behcet’s disease. Yonsei Med J. 2007;48:573–85.CrossRef
13.
go back to reference Fitzpatrick SG, Cohen DM, Clark AN. Ulcerated lesions of the oral mucosa: clinical and histologic review. Head Neck Pathol. 2019;13:91–102.CrossRef Fitzpatrick SG, Cohen DM, Clark AN. Ulcerated lesions of the oral mucosa: clinical and histologic review. Head Neck Pathol. 2019;13:91–102.CrossRef
14.
go back to reference Roett MA. Genital ulcers: differential diagnosis and management. Am Fam Phys. 2020;101:355–61. Roett MA. Genital ulcers: differential diagnosis and management. Am Fam Phys. 2020;101:355–61.
15.
go back to reference George C, Deroide F, Rustin M. Pyoderma gangrenosum—a guide to diagnosis and management. Clin Med (Lond). 2019;19:224–8.CrossRef George C, Deroide F, Rustin M. Pyoderma gangrenosum—a guide to diagnosis and management. Clin Med (Lond). 2019;19:224–8.CrossRef
16.
go back to reference Vinokur M, Burkett JG. Headache in Behçet’s disease. Curr Pain Headache Rep. 2020;24:50.CrossRef Vinokur M, Burkett JG. Headache in Behçet’s disease. Curr Pain Headache Rep. 2020;24:50.CrossRef
17.
go back to reference Karadag O, Bolek EC. Management of Behcet’s syndrome. Rheumatology. 2020;59:108–17.CrossRef Karadag O, Bolek EC. Management of Behcet’s syndrome. Rheumatology. 2020;59:108–17.CrossRef
18.
go back to reference Ozguler Y, Hatemi G. Management of Behçet’s syndrome. Curr Opin Rheumatol. 2016;28:45–50.CrossRef Ozguler Y, Hatemi G. Management of Behçet’s syndrome. Curr Opin Rheumatol. 2016;28:45–50.CrossRef
Metadata
Title
Behçet’s Disease in a Polish Patient: A Case Report
Authors
Julia Nowowiejska
Anna Baran
Julita A. Krahel
Iwona Flisiak
Publication date
01-08-2021
Publisher
Springer Healthcare
Published in
Dermatology and Therapy / Issue 4/2021
Print ISSN: 2193-8210
Electronic ISSN: 2190-9172
DOI
https://doi.org/10.1007/s13555-021-00551-7

Other articles of this Issue 4/2021

Dermatology and Therapy 4/2021 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.